Senik A, Gisselbrecht S, Levy J P
Int J Cancer. 1975 Dec 15;16(6):960-70. doi: 10.1002/ijc.2910160610.
The SCRT and the inhibition test have been used to determine the specificity of cell surfacr antigens reacting with anti-M-MSV cytolytic lymphocytes. The method provides very sensitive and specific results. Some discrepancies exist between the results of SCRT and those obtained by the in vitro inhibition by tumor cells of cell-mediated immune cytolysis. The main point is that allogeneic cells are stimulatory in SCRT, whereas they are not reactive in the inhibition test. Several hypotheses are discussed to explain these discrepancies. In all the experiments, a strong secondary stimulation of cytotoxic lymphocytes was obtained in vitro when FMRGi (+) cells were used as stimulators, whatever the nature and the histocompatibility antigens of these cells. This suggests that an antigen of the "FMRGi system" is regularly involved in the cell-mediated anti-MSV reaction. However, other antigenic specificities of different natures are probably also concerned due to the antigenic complexity of these tumors.
SCRT和抑制试验已被用于确定与抗M-MSV溶细胞淋巴细胞反应的细胞表面抗原的特异性。该方法提供了非常敏感和特异的结果。SCRT的结果与肿瘤细胞在体外抑制细胞介导的免疫细胞溶解所获得的结果之间存在一些差异。主要问题是,同种异体细胞在SCRT中具有刺激作用,而在抑制试验中无反应。讨论了几种假说来解释这些差异。在所有实验中,无论这些细胞的性质和组织相容性抗原如何,当使用FMRGi(+)细胞作为刺激物时,在体外均可获得细胞毒性淋巴细胞的强烈二次刺激。这表明“FMRGi系统”的一种抗原经常参与细胞介导的抗MSV反应。然而,由于这些肿瘤的抗原复杂性,可能还涉及其他不同性质的抗原特异性。